Financing ·
AstraZeneca Finance LLC announced that four series of debt securities totaling €2.55 billion have been admitted to…
AZNAstrazeneca PLC
AstraZeneca Finance LLC announced that four series of debt securities totaling €2.55 billion have been admitted to trading on the London Stock Exchange as of September 1, 2026. The issuance includes EUR 700 million in 3.402% notes due March 2030, EUR 600 million in 3.652% notes due September 2032, EUR 500 million in 3.923% notes due September 2035, and EUR 750 million in 4.169% notes due September 2038. AstraZeneca PLC is a global biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines.